Financial statements Ams Pharma

Balance sheet of Ams Pharma

Company age:
Age:
12 y. 9 m. 11 d.
Share capital:
Share capital:
10 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of AMS PHARMA

Year
2018
2020
2021
2022
2023
Total assets 682 828,82 769 332,91 567 687,65 365 575,21 314 110,57
A. Fixed assets - 3 550,04 0,00 5 726,18 3 949,14
B. Current assets 681 378,33 765 294,77 566 150,20 359 849,03 310 161,43
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 682 828,82 769 332,91 567 687,65 365 575,21 314 110,57
A. Equity 140 788,89 202 511,55 199 154,67 15 937,91 34 446,49
B. Liabilities and provisions for liabilities 542 039,93 566 821,36 368 532,98 349 637,30 279 664,08
I. Long-term liabilities 173 800,00 100 000,00 64 500,00 91 500,00 29 500,00
II. Short-term liabilities 368 239,93 364 921,36 304 032,98 258 137,30 250 164,08
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.